Latest News
Search News
Tackling blood cancer with Blood Cancer UK
10th September 2021
This Blood Cancer Awareness Month, find out about the Blood Cancer UK-funded research projects currently underway at the Barts Cancer Institute, which span from looking at the specific genetic changes that drive blood cancer development, to identifying new treatment strategies to improve the outcomes for patients.
Read more
BCI researcher receives UKRI Future Leaders Fellowship Award
9th September 2021
Dr Benjamin Werner from Barts Cancer Institute, Queen Mary University of London, is one of the next generation of UK science leaders to receive funding through UK Research and Innovation’s (UKRI) Future Leaders Fellowships scheme. Dr Werner will receive an award of approximately £1.4 million, which will support a research project looking at the evolutionary dynamics of circular extra-chromosomal DNA (ecDNA) in human cancers.
Read more
Combining medicine with blood cancer research
3rd September 2021
This Blood Cancer Awareness Month, we spoke with Dr John Riches, Clinical Senior Lecturer at Barts Cancer Institute (BCI), Queen Mary University of London. Dr Riches is a clinician scientist who splits his time between BCI where he leads a group researching blood cancer in our Centre for Haemato-Oncology and directs the MSc Cancer & Clinical Oncology Programme, and St Bartholemew’s Hospital where he treats blood cancer patients.
Read more
Miguel Ganuza receives ASH Global Research Award
24th August 2021
Congratulations to Dr Miguel Ganuza from Barts Cancer Institute, Queen Mary University of London, who has been selected by the American Society of Hematology (ASH) to receive the 2021 ASH Global Research Award. Dr Ganuza is one of twelve talented early-career investigators selected for this award.
Read more
HPV screening for cervical cancer prevention
3rd August 2021
Professor Jack Cuzick, Director of the Wolfson Institute of Preventive Medicine at Queen Mary University of London and Theme Lead for Cancer Prevention & Risk Reduction at the Cancer Research UK Barts Centre, has been awarded a Queen Mary Impact Award for his research on human papilloma virus (HPV) screening for cervical cancer, which has transformed cervical cancer prevention programmes worldwide.
Read more
Dissecting complex biological pathways with machine learning
19th July 2021
We spoke with Group Leader Dr Jun Wang and Postdoctoral Researcher Dr Anthony Anene from Barts Cancer Institute’s Centre for Cancer Genomics & Computational Biology about their most recent publication. Published in Patterns, the paper describes the development of a machine-learning tool called ACSNI that can be used to predict tissue-specific pathway components from large biological datasets.
Read more